Description
The Special Access Programme (SAP) provides access to nonmarketed drugs for practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable. The SAP authorizes a manufacturer to sell a drug that cannot otherwise be sold or distributed in Canada.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products | HTML | Open resource | |
| Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products | HTML | Open resource |